ACAD
30.26
-0.17
-0.56%
AEMD
2.08
+0.02
+0.97%
APRI
1.05
-0.03
-2.78%
ARNA
24.021
-0.029
-0.1214%
ATEC
1.76
+0.03
+2.03%
CNAT
6.02
-0.02
-0.33%
CRXM
0.169
0.00
0.00%
CYTX
0.42
-0.69
-62.1532%
DXCM
69.49
-0.03
-0.04%
GNMK
11.89
-0.16
-1.33%
HALO
13.52
-0.01
-0.07%
ILMN
172.695
-0.055
-0.032%
INNV
0.12
0.00
+3.45%
INO
5.991
-0.019
-0.316%
ISCO
1.22
-0.01
-0.81%
ISIS
57.56
0.00
0.00%
LGND
123.43
+0.38
+0.31%
LPTN
2.93
-2.93
-100.00%
MBVX
0.933
-0.027
-2.7917%
MEIP
3
-0.02
-0.66%
MNOV
5.43
+0.12
+2.26%
MRTX
4.8
-0.1
-2.04%
MSTX
0.131
-0.007
-5.278%
NBIX
46.795
-0.275
-0.584%
NUVA
79.77
-0.15
-0.19%
ONCS
1.096
+0.016
+1.4352%
ONVO
2.37
+0.05
+2.16%
OREX
2.44
-0.03
-1.21%
OTIC
18.85
-0.05
-0.26%
QDEL
37.65
-0.06
-0.16%
RCPT
231.96
0.00
0.00%
RGLS
0.953
-0.027
-2.743061%
RMD
77.1
+0.1
+0.13%
SCIE
0
0.00
-33.3333%
SPHS
2.1
+0.03
+1.45%
SRNE
2.075
+0.025
+1.220%
TROV
1
+0.04
+4.17%
VICL
2.69
+0.03
+1.13%
VOLC
18
0.00
0.00%
ZGNX
13.3
-0.1
-0.75%
ACAD
30.26
-0.17
-0.56%
AEMD
2.08
+0.02
+0.97%
APRI
1.05
-0.03
-2.78%
ARNA
24.021
-0.029
-0.1214%
ATEC
1.76
+0.03
+2.03%
CNAT
6.02
-0.02
-0.33%
CRXM
0.169
0.00
0.00%
CYTX
0.42
-0.69
-62.1532%
DXCM
69.49
-0.03
-0.04%
GNMK
11.89
-0.16
-1.33%
HALO
13.52
-0.01
-0.07%
ILMN
172.695
-0.055
-0.032%
INNV
0.12
0.00
+3.45%
INO
5.991
-0.019
-0.316%
ISCO
1.22
-0.01
-0.81%
ISIS
57.56
0.00
0.00%
LGND
123.43
+0.38
+0.31%
LPTN
2.93
-2.93
-100.00%
MBVX
0.933
-0.027
-2.7917%
MEIP
3
-0.02
-0.66%
MNOV
5.43
+0.12
+2.26%
MRTX
4.8
-0.1
-2.04%
MSTX
0.131
-0.007
-5.278%
NBIX
46.795
-0.275
-0.584%
NUVA
79.77
-0.15
-0.19%
ONCS
1.096
+0.016
+1.4352%
ONVO
2.37
+0.05
+2.16%
OREX
2.44
-0.03
-1.21%
OTIC
18.85
-0.05
-0.26%
QDEL
37.65
-0.06
-0.16%
RCPT
231.96
0.00
0.00%
RGLS
0.953
-0.027
-2.743061%
RMD
77.1
+0.1
+0.13%
SCIE
0
0.00
-33.3333%
SPHS
2.1
+0.03
+1.45%
SRNE
2.075
+0.025
+1.220%
TROV
1
+0.04
+4.17%
VICL
2.69
+0.03
+1.13%
VOLC
18
0.00
0.00%
ZGNX
13.3
-0.1
-0.75%
Home » Drug Discovery, Headline, SDBN Events

SDBN April 19th 2011 Event Featuring Celgene

Submitted by on March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one of the top ten fastest growing biotech stocks. Celgene has more than 4,000 employees worldwide, with important work being carried out at their San Diego location. David Webb, Vice President, Research & San Diego Site Director (Bio) will give a presentation titled “Celgene’s Drug Discovery Engine in San Diego” at our April 19th event.

As always, there will be plenty of time for networking, and we plan to do our ‘Introduce a Colleague’ activity which was very popular a few months ago. Sign up and we look forward to seeing you April 19th!

Sponsors

Contact us if you’d like to sponsor this event.

Event Details

Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network April 19th Event Featuring Celgene
When: Tuesday, April 19th 2011, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $25/$20 Academic, dinner provided, cash bar
Contact: http://sdbn.org/contact
For more information about the event: http://sdbn.org/april

Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks. Park on the street or in the structure just past (south of) Tango del Rey. DO NOT park in the Science Center lot.

Be Sociable, Share!